Loomis, Sayles & Company
TWST icon

Loomis, Sayles & Company’s Twist Bioscience TWST Stock Holding History

Loomis, Sayles & Company’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.6M Buy
861,309
+369,019
+75% +$24M 0.11% 69
2026
Q1 		$23.4M Buy
+492,290
New +$22.1M 0.03% 217

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Loomis, Sayles & Company's TWST Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Twist Bioscience (TWST) stake by 75% in Q2 2026, buying an estimated $24M and bringing the position to 861,309 shares worth $88.6M. The position accounts for 0.11% of the portfolio, ranked #69.

Loomis, Sayles & Company first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Loomis, Sayles & Company held 861,309 shares of Twist Bioscience worth $88.6M as of Q2 2026.
  • Loomis, Sayles & Company bought 369,019 Twist Bioscience shares in Q2 2026, an estimated $24M.
  • Twist Bioscience made up 0.11% of Loomis, Sayles & Company's portfolio in Q2 2026, its #69 holding.
  • Loomis, Sayles & Company first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.